Curex Review
Best for: affordable compounded GLP-1 with strong corporate transparency and pharmacy testing
Curex (Curex, Inc.) offers compounded semaglutide ($149/mo) and tirzepatide ($199/mo) in injectable and oral dissolving tablet formats. LegitScript certified. Available in 43+ states. No membership fee. Miami and NYC offices. Originally an allergy immunotherapy company.
then $199/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Billed separately
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Curex is a solid telehealth option with balanced features and pricing.
Curex at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $49/mo (ongoing anchored only as 'From $199/mo'; per-drug standard price no longer separately displayed; $49 = Summer Sale first month)
- What's included
- Medication · Consult · Shipping
- Availability
- 45 states
- FDA status
- No FDA warning letter on record
How we scored Curex
Each dimension is scored algorithmically from Curex’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.2/10At $199/mo, Curex runs about 17% above the $170 median for GLP-1 providers, and the first-month promo drops to $49.
Effectiveness25%
8.6/10Curex offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience — consult included in the price; 5 platform features disclosed.
Trust & Safety15%
8.5/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
8.6/10Curex treats patients in all 50 states.
Support10%
6.2/10Curex provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Curex review
Last checked 2026-06-06- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Curex offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
ongoing anchored only as 'From $199/mo'; per-drug standard price no longer separately displayed; $49 = Summer Sale first month
ongoing anchored only as 'From $199/mo'; per-drug standard price no longer separately displayed; $149 = Summer Sale first month
Ready to get started?
Plans and promotions change often — check Curex's current pricing and active discounts before you decide.
What we like
- LegitScript certified
- Named entity (Curex, Inc.) with two offices — Miami FL and NYC
- No membership fee ever
- Injectable and oral dissolving tablet formats
- Third-party lab testing via FDA/DEA certified labs
- Works with LabCorp and Quest Diagnostics
- 43+ state coverage with transparent exclusion list
- Ongoing pricing from $199/mo with no membership fee; first-month Summer Sale promos ($49 sema, $149 tirz)
Watch-outs
- Not available in AK, AR, CT, HI, MA, NM, MO
- Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
- Primary business is allergy immunotherapy — GLP-1 is a newer vertical
Curex: the allergy company that quietly built a low-cost GLP-1 program
Curex is one of the more unusual names in compounded weight-loss medicine, and the reason is right there in its corporate history: Curex, Inc. started life as an allergy immunotherapy company, not a GLP-1 telehealth brand. The weight-loss vertical is a newer addition. That background matters less than you'd think once you start using it, but it's the first thing to understand, because it explains both the strengths (a real company with two physical offices and an established testing infrastructure) and the honest caveat (GLP-1 isn't the founding business). If you want semaglutide or tirzepatide at a genuinely low monthly price, with no membership fee and an unusually long refund guarantee, Curex earns a look. If you want brand-name Ozempic, Wegovy, Zepbound, or Mounjaro, look elsewhere — Curex doesn't prescribe them and says so plainly.
How the pricing actually works (and why the headline number moved)
Curex anchors its current pricing at $199 a month with no membership fee and free shipping. That's the ongoing 'from' rate for either medication. On top of that it runs a first-month Summer Sale promo — $49 for the first month of semaglutide — which is the teaser you'll see splashed across the landing page. Tirzepatide's first month is discounted too, just not as steeply. For context, the category median for compounded GLP-1 hovers around $170 a month, so Curex's standing rate sits comfortably below the middle of the pack, and the promo undercuts almost everyone for the first 30 days.
A note on transparency: Curex used to publish separate standard prices for each drug, but the live GLP-1 page now anchors everything to the single $199 floor and leads with the promo. That's a common marketing move, but it does mean you should confirm your exact ongoing per-drug rate before you commit, rather than assuming the teaser price continues. See our scoring methodology for how we weigh promo-versus-ongoing pricing.
What's actually included
- Your medical intake review and prescription
- The medication itself
- Free shipping
- 24/7 access to the care team
- No membership or hidden fees — ever
The one thing not bundled in: labs. Curex's clinicians may occasionally recommend bloodwork or extra medications that the plan doesn't cover, and you'd use insurance for those. That's normal for the category, but worth knowing so the monthly price isn't mistaken for an all-in clinical number.
The medications — and the oral tablet option
Curex prescribes compounded semaglutide and compounded tirzepatide, and it offers both in two formats: the standard subcutaneous injection and an oral dissolving tablet. The oral tablet is the differentiator a lot of needle-averse patients are looking for — it's the same active drug in a form you don't have to inject. It's worth being clear-eyed that these are compounded medications, not the FDA-approved branded pens, so the data behind exact dosing equivalence is thinner than for the brand products. But if compounded GLP-1 is what you're after and you'd rather not inject, the tablet format is a real, uncommon perk here.
What genuinely sets Curex apart: testing and corporate substance
In a space crowded with thin telehealth shells, Curex reads as a real company. It's a named entity — Curex, Inc. — with offices in Miami and New York, and it's LegitScript certified, which is the baseline credential you actually want to see from a compounded-medication seller. More distinctively, Curex leans on third-party lab testing through FDA/DEA certified labs and maintains working relationships with LabCorp and Quest Diagnostics. That testing posture is partly a holdover from the allergy-diagnostics side of the business, and it's a meaningful trust signal: someone other than the seller is checking the product. There are no FDA warning letters on file for Curex in our records, and no red flags on its compounding sourcing in what we could verify.
The 365-day money-back guarantee
Curex advertises a 365 Day Money Back Guarantee with a full refund if you're not prescribed. Read that carefully — the strongest, cleanest part of the guarantee is the refund if you complete the intake and a clinician declines to prescribe, so you're not paying for a non-starter. A year-long window is unusually generous on paper; just confirm the exact terms and what 'not prescribed' covers before you treat it as a no-questions-asked promise.
Who should choose Curex — and who should skip it
Curex is a strong fit if you want affordable compounded GLP-1, hate the idea of a recurring membership fee, like the safety net of third-party lab testing, and are intrigued by the oral tablet option. The no-membership, free-shipping, everything-included structure keeps the math simple, and the corporate transparency is better than most budget competitors.
Skip it if you live in Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico, or Missouri — Curex doesn't operate there, though it covers 43-plus states and publishes the exclusion list openly. Skip it, too, if you specifically want a brand-name pen and insurance billing, or if the fact that weight loss is a secondary vertical for an allergy company gives you pause. That's a fair concern; it just hasn't shown up as a quality problem in what we reviewed.
Bottom line
Curex is a credible, low-cost compounded GLP-1 option with a few genuinely uncommon features: an oral dissolving tablet alternative to injections, third-party lab testing through certified labs, LegitScript certification, a real corporate footprint, and a year-long money-back guarantee. The pricing is competitive — $199 a month ongoing with no membership fee, and a first-month promo from $49 — provided you confirm your exact ongoing per-drug rate after the teaser period. It won't suit anyone set on brand-name medication or living in one of its excluded states, and the allergy-first origin story is worth knowing. But for budget-minded patients who value testing transparency and a needle-free format, Curex is one of the better-substantiated picks in the affordable tier.
For a side-by-side, RNK Health ($197/month) and Breeze Meds ($199/month) are the most comparable options to weigh against Curex.
Ready to start with Curex?
Starting at $49/month. See current pricing and start your free consultation.
Curex might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Curex
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Curex review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Curex?
Starting at $49/month. See current pricing and start your free consultation.